Researchers have developed an innovative device that can diagnose glioblastoma, an aggressive brain cancer, in under an hour using a novel biochip. The chip leverages electrokinetic technology to detect active Epidermal Growth Factor Receptors (EGFRs) in extracellular vesicles from a small blood sample. This method offers high sensitivity and selectivity, minimizing interference and potentially improving early detection. The technology could be adapted for diagnosing other diseases, enhancing its clinical impact.
Blood Sample Allows for Rapid Detection of Brain Cancer
